I n this study, the authors concluded that the histopathologic margin of excision affects the risk of local recurrence (LR) in patients with cutaneous melanoma Ͻ2 mm thick, although if the in vivo margin of excision is Ͼ1 cm, the margin no longer predicts risk of LR. 1 Patient survival was not affected by the margin of excision.
A problem common to this and many other studies on this subject is their lack of a biologically valid definition of LR. In the study by McKinnon et al, the definition used for LR was recurrence within 5 cm of the scar because that is the way recurrence was recorded in the Sydney Melanoma Unit database since the beginning of data collection. The authors asserted, furthermore, that there is no means of determining whether these are true LR or the result of local lymphatic spread or even hematogenous metastasis, and that "any definition of LR must remain arbitrary until there is a mechanism to trace the source of the tumor deposit that grows adjacent to an excision scar." Within this statement lies the crucial fault in perpetuating the controversy about the effect of margins of excision on risk of LR, that is the failure to acknowledge: 1) that true LR involves the primary excision site and cannot be defined in terms of any distance from that site, and 2) that local recurrence is due to either of 2 mechanisms: i) persistent growth of incompletely excised primary melanoma, and ii) local metastasis. [2] [3] [4] [5] In this study, no attempt was made to distinguish between these 2 quite distinct forms of so-called LR; it is not known, therefore, what the number of local metastases was in these cases. Mor-phologic evidence indicates that the 2 types of LR can be distinguished according to their histopathologic features, 4 and survival studies show that the prognosis for the 2 types of LR are correspondingly different. 6 In this study, the 5-year survival after LR was only 52.8%, a much lower rate than expected for patients with primary melanomas of that thickness without evidence of metastasis (clinical stage 1).
It seems likely, therefore, that LR in this study included a large proportion of metastatic lesions. Without rigorous histologic review of the primary neoplasms and the LR, however, this study has neglected an opportunity to provide the information essential to the understanding of the effect of excision margins on the risk of so-called LR. Until clinicians and pathologists alike recognize the importance of the distinction between the 2 types of LR, this issue will remain controversial due to a fundamental misconception about the true nature of LR and its implications for prognosis.
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Reply:
I thank Prof. Heenan for his interest in our study. He raises 2 main points: 1) local recurrence (LR) of melanoma comes in 2 recognizable forms, each with a different prognosis; and 2) the LR in our series was likely not "true" LR but was indeed local metastases. It may indeed be possible to examine a specimen of LR and conclude, perhaps on the basis of residual in situ disease, that it is persistent and not metastatic. However, the importance of this observation is limited and evidence for a different prognosis for "local metastases" is lacking.
The reference for Prof. Heenan's assertion that different forms of LR have different survival is a textbook, which in turn cites 2 retrospective series by Drzewiecki and Andersson 1 and Brown and Zitelli. 2 The first report described a series of 46 patients with LR but identified only 5 with a primary resection that had histologically clear margins. Brown and Zitelli reported on 50 patients with LR who underwent Moh's micrographic surgery. Excellent survival was reported. However, no information was given on the completeness of the primary excision and more than 50% of the recurrences were in situ disease. These 2 studies describe patients who had various forms of inadequate resection, usually because of misdiagnosis, and are not comparable to our report. Perhaps it should not be surprising that melanoma will persist and grow if it is not removed in the first place. All patients in our series had a surgical excision with histologically clear margins. The question asked was whether wider excision beyond that point was predictive of outcome.
The existing randomized trials that compared resection margins appropriately defined LR according to what was clinically important to patient treatment and prognosis, that is, recurrence in proximity to the excision scar. [3] [4] [5] Our study, using similar criteria, demonstrates that LR has a similar prognosis to in transit disease, suggesting a similar pathophysiology. For melanomas Յ2 mm thick, a surgical margin beyond 1 cm does not predict either LR or overall survival. I believe that these are important observations for the practic-
